Suppr超能文献

慢性肾脏病中钠摄入量的评估:从测量方法到临床结局

Sodium Intake Estimation in Chronic Kidney Disease: From Measurement Methods to Clinical Outcomes.

作者信息

Afsar Baris, Afsar Rengin Elsurer, Bastani Bahar, Rub Fadee Abu Al, Caliskan Yasar, Lentine Krista L

机构信息

Saint Louis University, School of Medicine, Division of Nephrology, St. Louis, MO, USA.

出版信息

Turkish J Nephrol. 2025 Jul;34(3):160-168. doi: 10.5152/turkjnephrol.2025.25922. Epub 2025 Jul 1.

Abstract

BACKGROUND

The interrelationship of sodium/salt consumption and chronic kidney disease (CKD) development and/or progression is inconsistent. Difference in the methods to evaluate sodium/salt intake may be one reason for this finding. The measurement of sodium/salt intake is challenging in CKD due to alterations in circadian sodium handling and creatinine kinetics (as sodium estimation formulas use creatinine), day to day variation of urine output, recall bias and cognitive dysfunction. This paper aims to present an overview of the methods to estimate sodium/salt intake in patients with CKD.

METHODS

We conducted a review of existing literature regarding the methods used to estimate sodium/salt intake in patients with CKD. PubMed, Embase, Cochrane Library, and Web of Science databases were searched. To make extensive search strategy; key terms were kept broad and included as "24-hour urinary sodium excretion and chronic kidney disease", "Spot urinary sodium and chronic kidney disease", "Food frequency questionnaires, sodium and chronic kidney disease", "Food records, sodium and chronic kidney disease". Food recalls, sodium and chronic kidney disease".

RESULTS

Although there are many methods to measure sodium intake in patients with CKD, none of them is perfect including 24-hour urinary sodium excretion. Furthermore, most of the formulas are derived from healthy population. Although CKD specific formulas exists; they are scarce and mostly not externally validated.

CONCLUSIONS

Each method to estimate sodium intake have specific advantages and disadvantages in patients with CKD. More research is necessary to find better methods to estimate sodium intake in patients with CKD.

摘要

背景

钠/盐摄入量与慢性肾脏病(CKD)发生和/或进展之间的相互关系并不一致。评估钠/盐摄入量的方法存在差异可能是导致这一结果的原因之一。由于昼夜钠代谢和肌酐动力学的改变(因为钠估算公式使用肌酐)、尿量的每日变化、回忆偏倚和认知功能障碍,在CKD患者中测量钠/盐摄入量具有挑战性。本文旨在概述CKD患者钠/盐摄入量的估算方法。

方法

我们对有关CKD患者钠/盐摄入量估算方法的现有文献进行了综述。检索了PubMed、Embase、Cochrane图书馆和科学网数据库。为制定广泛的检索策略,关键词保持宽泛,包括“24小时尿钠排泄与慢性肾脏病”、“随机尿钠与慢性肾脏病”、“食物频率问卷、钠与慢性肾脏病”、“食物记录、钠与慢性肾脏病”、“食物回忆、钠与慢性肾脏病”。

结果

尽管有多种方法可用于测量CKD患者的钠摄入量,但包括24小时尿钠排泄在内,没有一种方法是完美的。此外,大多数公式是从健康人群中推导出来的。虽然存在CKD特异性公式,但数量稀少且大多未经过外部验证。

结论

在CKD患者中,每种估算钠摄入量的方法都有其特定的优缺点。需要进行更多研究以找到更好的方法来估算CKD患者的钠摄入量。

相似文献

3
Altered dietary salt intake for people with chronic kidney disease.慢性肾病患者饮食中盐摄入量的改变
Cochrane Database Syst Rev. 2015 Feb 18(2):CD010070. doi: 10.1002/14651858.CD010070.pub2.
7
Protein restriction for diabetic kidney disease.限制蛋白质摄入治疗糖尿病肾病。
Cochrane Database Syst Rev. 2023 Jan 3;1(1):CD014906. doi: 10.1002/14651858.CD014906.pub2.
8
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.

本文引用的文献

1
Transient High Salt Intake Promotes T-Cell-Mediated Hypertensive Vascular Injury.短暂高盐摄入促进 T 细胞介导的高血压血管损伤。
Hypertension. 2024 Dec;81(12):2415-2429. doi: 10.1161/HYPERTENSIONAHA.124.23115. Epub 2024 Oct 16.
2
Sodium Management in Kidney Disease: Old Stories, New Tricks.肾脏疾病中的钠管理:旧故事,新技巧。
Semin Nephrol. 2023 Mar;43(2):151407. doi: 10.1016/j.semnephrol.2023.151407. Epub 2023 Aug 26.
9
Sodium Reduction: How Big Might the Risks and Benefits Be?钠的减少:风险和收益可能有多大?
Heart Lung Circ. 2021 Feb;30(2):180-185. doi: 10.1016/j.hlc.2020.07.011. Epub 2020 Aug 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验